Why partner with UCL Ventures
A trusted gateway to UCL’s most compelling investment opportunities
30+
years of experience
£4.5bn
capital raised since 2016
18
therapeutics in pipeline
1400+
patents files since 1993
UCL Ventures brings highly-investable, high-potential ventures backed by world-class science, and driven by exceptional founders and proven teams.
As one of the world’s leading university technology transfer operations, our team of commercialisation experts have backgrounds in industry, deal-making, licensing, fund structures and much more.
Why partner with us?
One of the UK’s few self-sufficient, self-funding university commercialisation partners.
Our spinout ventures raised have £3.06 billion in external investment since 2020.
Five spinouts made their IPO on NASDAQ and we have multiple high-value exits.
Our unique Portico Ventures model helps rapidly set up tech spinouts in fast-moving sectors.
Our Technology Investment Funds have crowded-in investment into UCL spinout ventures for over the last ten years – helping grow successful businesses such as Autolus and Phasecraft.
And we are not stopping there! Our next investment vehicle promises to be a quantum leap forward...
Portfolio highlights
Neurology & brain sciences
Trace Neuroscience
Genomic medicine for neurodegenerative diseases, with a focus on ALS.
Energy & cleantech
Oriole Networks
Photonics accelerating AI and ML in a low-carbon world.
Interested in partnering with us?
With a track record of success and connection to one of the world's leading universities, UCL Ventures is a trusted partner.
Get in touch